Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

SHSE:600332 Stock Report

Market Cap: CN¥43.1b

Guangzhou Baiyunshan Pharmaceutical Holdings Balance Sheet Health

Financial Health criteria checks 4/6

Guangzhou Baiyunshan Pharmaceutical Holdings has a total shareholder equity of CN¥38.1B and total debt of CN¥13.5B, which brings its debt-to-equity ratio to 35.5%. Its total assets and total liabilities are CN¥79.3B and CN¥41.2B respectively. Guangzhou Baiyunshan Pharmaceutical Holdings's EBIT is CN¥3.9B making its interest coverage ratio -20.6. It has cash and short-term investments of CN¥17.5B.

Key information

35.5%

Debt to equity ratio

CN¥13.50b

Debt

Interest coverage ratio-20.6x
CashCN¥17.47b
EquityCN¥38.05b
Total liabilitiesCN¥41.20b
Total assetsCN¥79.26b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 600332's short term assets (CN¥53.1B) exceed its short term liabilities (CN¥36.3B).

Long Term Liabilities: 600332's short term assets (CN¥53.1B) exceed its long term liabilities (CN¥4.9B).


Debt to Equity History and Analysis

Debt Level: 600332 has more cash than its total debt.

Reducing Debt: 600332's debt to equity ratio has increased from 28.2% to 35.5% over the past 5 years.

Debt Coverage: 600332's debt is not well covered by operating cash flow (18.2%).

Interest Coverage: 600332 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies